Gospodarowicz, M. K., Brierley, J. D. & Wittekind, C. (eds) TNM Classification of Malignant Tumours (Wiley, 2017).

DeVita, V. T. Jr, Young, R. C. & Canellos, G. P. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer 35, 98–110 (1975).

Article  PubMed  Google Scholar 

Woodhouse, J. R. & Ferry, D. R. The genetic basis of resistance to cancer chemotherapy. Ann. Med. 27, 157–167 (1995).

Article  CAS  PubMed  Google Scholar 

Kerr, D. J., Kerr, A. M., Wheldon, T. E. & Kaye, S. B. In vitro chemosensitivity testing using the multicellular tumour spheroid model. Cancer Drug. Deliv. 4, 124–130 (1987).

Article  Google Scholar 

Kerr, D. J. et al. The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systems. Eur. J. Cancer Clin. Oncol. 23, 1315–1322 (1987).

Article  CAS  PubMed  Google Scholar 

Kerr, D. J., Wheldon, T. E., Kerr, A. M., Freshney, R. I. & Kaye, S. B. The effect of adriamycin and 4′-deoxydoxorubicin on cell survival on human lung tumour cells grown in monolayer and as spheroids. Br. J. Cancer 54, 423–429 (1986).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Midgley, R. & Kerr, D. Colorectal cancer. Lancet 353, 391–399 (1999).

Article  CAS  PubMed  Google Scholar 

Union for International Cancer Control. UICC 8th Edition Errata – 25th January 2022. UICC https://www.uicc.org/sites/default/files/atoms/files/UICC%20TNM%20Classification%208th%20ed.%20Errata%2025%20jan%202022.pdf (2022).

Betge, J. et al. Intramural and extramural vascular invasion in colorectal cancer. Cancer 118, 628–638 (2012).

Article  PubMed  Google Scholar 

Klaver, C. E. L. et al. Interobserver, intraobserver, and interlaboratory variability in reporting pT4a colon cancer. Virchows Arch. 476, 219–230 (2020).

Article  PubMed  Google Scholar 

Lim, J. H. et al. Comparison of long-term survival outcomes of T4a and T4b colorectal cancer. Front. Oncol. 11, 780684 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Kojima, M. et al. Pathological diagnostic criterion of blood and lymphatic vessel invasion in colorectal cancer: a framework for developing an objective pathological diagnostic system using the Delphi method, from the Pathology Working Group of the Japanese Society for Cancer of the Colon and Rectum. J. Clin. Pathol. 66, 551–558 (2013).

Article  PubMed  Google Scholar 

Messenger, D. E., Driman, D. K., McLeod, R. S., Riddell, R. H. & Kirsch, R. Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J. Clin. Pathol. 64, 983–989 (2011).

Article  PubMed  Google Scholar 

Maguire, A. & Sheahan, K. Controversies in the pathological assessment of colorectal cancer. World J. Gastroenterol. 20, 9850–9861 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Harris, E. I. et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am. J. Surg. Pathol. 32, 1816–1821 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Compton, C. C. Optimal pathologic staging: defining stage II disease. Clin. Cancer Res. 13, 6862s–6870s (2007).

Article  PubMed  Google Scholar 

Welch, D. R. & Hurst, D. R. Defining the hallmarks of metastasis. Cancer Res. 79, 3011–3027 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez, D. et al. Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis. Clin. Transl. Oncol. 23, 657–662 (2021).

Article  CAS  PubMed  Google Scholar 

Moertel, C. G. et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322, 352–358 (1990).

Article  CAS  PubMed  Google Scholar 

Gray, R., Barnwell, J., McConkey, C., Williams, N. & Kerr, D. J. QUASAR: a randomised study of adjuvant chemotherapy versus observation including 3239 colorectal cancer patients QUASAR Collaborative Group. Lancet 370, 2020–2029 (2007).

PubMed  Google Scholar 

Twelves, C. et al. Capecitabine as adjuvant treatment for stage III colon cancer. N. Engl. J. Med. 352, 2696–2704 (2005).

Article  CAS  PubMed  Google Scholar 

Tomita, N. et al. Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study. Br. J. Cancer 120, 689–696 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

André, T. et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J. Clin. Oncol. 33, 4176–4187 (2015).

Article  PubMed  Google Scholar 

Haller, D. G. et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J. Clin. Oncol. 29, 1465–1471 (2011).

Article  CAS  PubMed  Google Scholar 

Schmoll, H.-J. et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J. Clin. Oncol. 25, 102–109 (2007).

Article  CAS  PubMed  Google Scholar 

Gallois, C. et al. Prognostic impact of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer: an ACCENT/IDEA pooled analysis of 11 adjuvant trials. J. Clin. Oncol. 41, 803–815 (2023).

Article  CAS  PubMed  Google Scholar 

Douillard, J. Y. et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355, 1041–1047 (2000).

Article  CAS  PubMed  Google Scholar 

Van Cutsem, E. et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J. Clin. Oncol. 27, 3117–3125 (2009).

Article  PubMed  Google Scholar 

Alberts, S. R. et al. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 307, 1383–1393 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rachel, S. K. et al. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Lancet Oncol. 17, 1543–1557 (2016).

Article  Google Scholar 

Taieb, J. et al. Adjuvant FOLFOX +/ cetuximab in full RAS and BRAF wildtype stage III colon cancer patients. Ann. Oncol. 28, 824–830 (2017).

Article  CAS  PubMed  Google Scholar 

QASAR Collaborative Group Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 355, 1588–1596 (2000).

Article  Google Scholar 

Des Guetz, G., Nicolas, P., Perret, G.-Y., Morere, J.-F. & Uzzan, B. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur. J. Cancer 46, 1049–1055 (2010).

Article  PubMed  Google Scholar 

André, T. et al. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 21, 1620–1629 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Iveson, T. J. et al. Duration of adjuvant doublet chemotherapy (3 or 6 months) in patients with high-risk stage II colorectal cancer. J. Clin. Oncol. 39, 631–641 (2021). Erratum in: J Clin Oncol. 39(15), 1691 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Argiles, G. et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1291–1305 (2020).

Article  CAS  PubMed  Google Scholar 

Haller, D. G. et al. Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials. Ann. Oncol. 26, 715–724 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lorenzo Dottorini, F. P. et al. Oxaliplatin in adjuvant colorectal cancer: is there a role in older patients? J. Clin. Oncol. 41, 3300–3303 (2023).

Article  PubMed  Google Scholar 

Morton, D. et al. Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J. Clin. Oncol. 41, 1541–1552 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar